Although overexpression of CDKN3 has been associated with inhibition of cell proliferation in colon cancer cell lines [62], it has also been found to be overexpressed in breast, prostate, and lung cancers [63]–[65]. This evidence concerns the gene CDKN3 and malignant colon neoplasm.